Results 281 to 290 of about 43,089 (386)

Predictive value of left ventricular myocardial constructive work in patients with heart failure with preserved ejection fraction and preclinical diastolic dysfunction. [PDF]

J Cardiovasc Imaging
Chilingaryan A, Tunyan L, Arzumanyan M, Balyan H.   +3 more
europepmc   +1 more source

Impact of different training modalities on high‐density lipoprotein function in HFpEF patients: a substudy of the OptimEx trial

, 2022
Pamela W. Sowa, Ephraim B. Winzer, Jennifer Hommel, Anita Männel, Emeline M. Van Craenenbroeck, Ulrik Wisløff, Burkert Pieske, Martin Halle, Axel Linke, Volker Adams   +9 more
openalex   +2 more sources

Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS‐HF trial

European Journal of Heart Failure, EarlyView.
The beneficial effects of finerenone in patients with heart failure (HF) and mildly reduced or preserved ejection fraction were consistent, regardless of a history of chronic obstructive pulmonary disease (COPD) status. BMI, body mass index; LVEF, left ventricular ejection fraction; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide.
Jawad H. Butt, Pardeep S. Jhund, Alasdair D. Henderson, Brian L. Claggett, Akshay S. Desai, Carolyn S.P. Lam, Katharina Mueller, Markus F. Scheerer, Prabhakar Viswanathan, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faiez Zannad, Bertram Pitt, Muthiah Vaduganathan, Scott D. Solomon, John J.V. McMurray   +16 more
wiley   +1 more source

Artificial Intelligence-Guided Neuromodulation in Heart Failure with Preserved and Reduced Ejection Fraction: Mechanisms, Evidence, and Future Directions. [PDF]

J Cardiovasc Dev Dis
Ansari RA, Senapati SG, Ahluwalia V, Panjwani GAR, Kaur A, Yerrapragada G, Jayapradhaban Kala J, Elangovan P, Karuppiah SS, Asadimanesh N, Muthyala A, Arunachalam SP.   +11 more
europepmc   +1 more source

The interaction between atrial fibrillation and mitral regurgitation: Insights from the CABANA randomized clinical trial

European Journal of Heart Failure, EarlyView.
Effects of baseline mitral regurgitation in the CABANA trial: randomization to catheter ablation versus drug therapy in patients with atrial fibrillation. AF, atrial fibrillation; CCS, Canadian Cardiovascular Society; MR, mitral regurgitation; NYHA, New York Heart Association; OR, odds ratio.
Sebastiaan Dhont, Philippe B. Bertrand, Jonas Erzeel, Sébastien Deferm, Laurent Pison, Pieter M. Vandervoort, Wilfried Mullens, W.H. Wilson Tang, Pieter Martens   +8 more
wiley   +1 more source

Specific targeting of adipose tissue metabolism is superior to caloric restriction in treating obesity-related HFpEF. [PDF]

Cardiovasc Diabetol
Sedej S, Stockner A, Schreiber R, Diwan A, Breinbauer R, Abdellatif M.   +5 more
europepmc   +1 more source

Weighty Matters in HFpEF and Aging

JACC: Heart Failure, 2018
Bret H. Goodpaster, Daniel E. Forman
openaire   +2 more sources

The efficacy of finerenone on hierarchical composite endpoint analysed using win statistics in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of FINEARTS‐HF

European Journal of Heart Failure, EarlyView.
Effect of finerenone on a hierarchical endpoint. CI, confidence interval; CV, cardiovascular; EF, ejection fraction; HF, heart failure. ABSTRACT Aims FINEARTS‐HF demonstrated the efficacy of finerenone in reducing total worsening heart failure (HF) events (first and recurrent) and cardiovascular death, compared to placebo, in patients with HF and ...
Toru Kondo, Pardeep S. Jhund, Alasdair D. Henderson, Brian L. Claggett, Akshay S. Desai, Meike Brinker, James Lay‐Flurrie, Patrick Schloemer, Prabhakar Viswanathan, Flaviana Amarante, Chern‐En Chiang, Gerasimos Filippatos, Carolyn S.P. Lam, Mark C. Petrie, Michele Senni, Morten Schou, Subodh Verma, Adriaan A. Voors, Dirk von Lewinski, Faiez Zannad, Bertram Pitt, Muthiah Vaduganathan, Scott D. Solomon, John J.V McMurray   +23 more
wiley   +1 more source

Pulmonary Hypertension in HFpEF and HFrEF: JACC Review Topic of the Week.

Journal of the American College of Cardiology, 2020
M. Guazzi, S. Ghio, Y. Adir
semanticscholar   +1 more source

Mitochondrial targets in ischaemic heart disease and heart failure, and their potential for a more efficient clinical translation. A scientific statement of the ESC Working Group on Cellular Biology of the Heart and the ESC Working Group on Myocardial Function

European Journal of Heart Failure, EarlyView.
Improving clinical translation of mitoprotective therapies. 31P MRI, phosphorus‐31 magnetic resonance imaging; hiPSC‐CM, human‐induced pluripotent stem cell‐derived cardiomyocyte; IHD, ischaemic heart disease. Abstract Acute myocardial infarction (MI) remains a major cause of death and disability worldwide.
Melanie Paillard, Mahmoud Abdellatif, Ioanna Andreadou, Christian Bär, Luc Bertrand, Bianca J.J.M. Brundel, Gemma Chiva‐Blanch, Sean M. Davidson, Dana Dawson, Fabio Di Lisa, Paul Evans, Zoltan Giricz, Derek J. Hausenloy, Petra Kleinbongard, Frank Lezoualc'h, Elisa Liehn, Christoph Maack, Ange Maguy, Elizabeth Murphy, Cinzia Perrino, Maurizio Pesce, Peter P. Rainer, Katrin Streckfuss‐Bömeke, Matthias Thielmann, Rong Tian, Carlo G. Tocchetti, Jolanda Van Der Velden, Sophie Van Linthout, Serena Zacchigna, Thomas Krieg   +29 more
wiley   +1 more source